This is a StreetInsider.com Premium Only Page

TherapeuticsMD (TXMD) – StreetInsider.com Reports

Nov 14, 2023 05:11 PM TherapeuticsMD (TXMD) Tops Q3 EPS by 2c

Aug 14, 2023 07:00 AM TherapeuticsMD (TXMD) Misses Q2 EPS by 17c

May 15, 2023 04:34 PM TherapeuticsMD (TXMD) Reports Q1 Loss of $0.24/sh

Jan 10, 2023 01:03 PM Cantor Fitzgerald Reinstates TherapeuticsMD (TXMD) at Neutral

Nov 14, 2022 04:14 PM TherapeuticsMD (TXMD) Misses Q3 EPS by $1.09

Oct 31, 2022 06:53 AM TherapeuticsMD (TXMD) Announces $7M Private Placement of Preferred Stock

Oct 3, 2022 06:51 AM TherapeuticsMD (TXMD) Announces $7M Private Placement

Sep 12, 2022 06:51 AM TherapeuticsMD (TXMD) Appoints Brian Bernick and Mark Glickman as Interim Co-CEOs

Aug 1, 2022 06:51 AM TherapeuticsMD (TXMD) Announces $15M Common and Preferred Stock Placement with Rubric Capital

Jul 14, 2022 09:26 AM Pre-Open Movers: Bank Stock Fall on JP Morgan's Weak Results, Outlook

Jul 14, 2022 09:09 AM TherapeuticsMD (TXMD) evaluating strategic options, including Chapter 11

Jul 13, 2022 09:25 AM Pre-Open Movers: ironSource Surges on Buyback, Tech Stocks Fall on Hot CPI

Jul 13, 2022 07:44 AM Cantor Fitzgerald Reiterates Neutral Rating, $1 Price Target on TherapeuticsMD (TXMD) on Failed Acquisition

Jul 13, 2022 07:07 AM TherapeuticsMD (TXMD) Falls 46% After Announcing EW Healthcare Merger to Be Terminated After Unsuccessful Tender Offer

Jul 13, 2022 06:56 AM TherapeuticsMD (TXMD) Expects EW Healthcare Merger to Be Terminated After Unsuccessful Tender Offer

Jul 6, 2022 06:30 AM EW Healthcare Extends Tender Offer for TherapeuticsMD (TXMD)

Jun 7, 2022 06:08 AM H.C. Wainwright Downgrades TherapeuticsMD (TXMD) to Neutral

Jun 1, 2022 09:51 AM Increasing unusual option volume: VSCO ARCT SID RSI BKSY TXMD KHC

May 31, 2022 11:18 AM Increasing unusual option volume: TXMD TIP BMO BKSY GRAB MAT

May 31, 2022 09:19 AM Pre-Open Stock Movers 05/31: TherapeuticsMD, CatchMark Timber Trust, Yamana Gold Jump on Takeovers; Insulet Falls as Takeover Rumor Denied (more...)

May 31, 2022 06:05 AM TherapeuticsMD (TXMD) Aggress to be Acquired by EW Healthcare Partners for $10/Share

May 20, 2022 09:43 AM TherapeuticsMD (TXMD) Receives FDA Approval for sNDA for ANNOVERA

May 17, 2022 06:48 AM Cantor Fitzgerald Reiterates Neutral Rating on TherapeuticsMD (TXMD)

May 16, 2022 04:25 PM TherapeuticsMD (TXMD) Misses Q1 EPS by $1.69

May 6, 2022 03:33 AM Cantor Fitzgerald Downgrades TherapeuticsMD (TXMD) to Neutral

Mar 18, 2022 05:10 PM TherapeuticsMD (TXMD) Receives 180-Day Extension to Regain Nasdaq Compliance

Mar 10, 2022 11:05 AM Cantor Fitzgerald Reiterates TherapeuticsMD (TXMD) at Overweight, "TXMD's Opportunity to Become Leading Women's Healthcare Company Remains Underappreciated"

Mar 10, 2022 09:21 AM Pre-Open Stock Movers 03/10: (NTRA) (CRWD) (MQ) Higher; (ASAN) (TXMD) (FOSL) Lower (more...)

Mar 10, 2022 06:52 AM TherapeuticsMD (TXMD) Misses Q4 EPS by 2c

Mar 7, 2022 09:20 AM Pre-Open Stock Movers 03/07: (BBBY) (TXMD) (OXY) Higher; (ALPN) (SQSP) (BLUE) Lower (more...)

Mar 7, 2022 07:59 AM Cantor Fitzgerald Reiterates TherapeuticsMD (TXMD) at Overweight, $5 PT, VitaCare Sale is Good News, Priced Above Expectation, Increases Confidence in the Stock

Mar 7, 2022 07:40 AM TherapeuticsMD (TXMD) to Divest vitaCare to GoodRx (GDRX)

Jan 3, 2022 06:36 AM TherapeuticsMD (TXMD) Receives Approval from FDA of sNDA for BIJUVA

Dec 13, 2021 09:21 AM Pre-Open Stock Movers 12/13: (ARNA) (FHTX) (HOG) Higher; (NISN) (TXMD) (AMPE) Lower (more...)

Dec 10, 2021 04:31 PM FDA Does Not Approve TherapeuticsMD (TXMD) Requested Revisions to Manufacturing Testing Limits for ANNOVERA

Dec 8, 2021 06:51 AM TherapeuticsMD (TXMD) Settles US BIJUVA Patent Litigation with Amneal, Announces May 25, 2032 Generic Entry Date

Nov 11, 2021 06:51 AM TherapeuticsMD (TXMD) Misses Q3 EPS by 1c

Nov 11, 2021 06:45 AM TherapeuticsMD (TXMD) Appoints Hugh O’Dowd as CEO

Aug 4, 2021 06:52 AM TherapeuticsMD (TXMD) Reports In-Line Q2 EPS

May 25, 2021 06:51 AM TherapeuticsMD (TXMD) Announces Submission of Low Dose BIJUVA 0.5 mg/100 mg Supplemental New Drug Application to FDA

May 6, 2021 02:00 PM TherapeuticsMD (TXMD) PT Lowered to $5 at Stifel

May 6, 2021 07:11 AM TherapeuticsMD (TXMD) Tops Q1 EPS by 1c, Revenues Beat

Apr 9, 2021 09:31 AM Pre-Open Stock Movers 04/09: (CELC) (AFMD) (GLSI) Higher; (PRVB) (ITRM) (JKS) Lower (more...)

Apr 8, 2021 05:45 PM After-Hours Stock Movers 04/08: (CELC) (SUNW) (FUBO) Higher; (PRVB) (WDFC) (VBLT) Lower (more...)

Apr 8, 2021 04:07 PM TherapeuticsMD (TXMD) and Theramex Announce Approval of BIJUVE Capsules Indicated for Hormone Replacement Therapy in the United Kingdom and Under the Trade Name BIJUVA in Belgium

Apr 7, 2021 07:00 AM TherapeuticsMD (TXMD) PT Raised to $60 at Oppenheimer After Positive FDA Panel Vote on OCS Heart Device

Mar 2, 2021 03:44 PM TherapeuticsMD (TXMD) PT Lowered to $6 at Stifel, Following Earnings

Mar 2, 2021 07:12 AM TherapeuticsMD (TXMD) Misses Q4 EPS by 5c

Feb 11, 2021 09:24 AM Pre-Open Stock Movers 02/11: (ACIU) (MVIX) (DMTK) Higher; (FLDM) (ELY) (TLRY) Lower (more...)

Feb 11, 2021 09:03 AM TherapeuticsMD (TXMD) Prices $110M Share Common Offering